Recettori per l'adenosina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Recettori per l'adenosina" in Italian language version.

refsWebsite

Global rank Italian rank

4^th place

9^th place

2^nd place

7^th place

799^th place

22^nd place

1aspetjournals.org

6,663^rd place

5,217^th place

565^th place

723^rd place

1web.archive.org

1^st place

1^st place

aspetjournals.org

pharmrev.aspetjournals.org

Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J, International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, in Pharmacol. Rev., vol. 53, n. 4, 2001, pp. 527–52, PMID 11734617.

doi.org

dx.doi.org

Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M, Towards a revised nomenclature for P1 and P2 receptors, in Trends Pharmacol. Sci., vol. 18, n. 3, 1997, pp. 79–82, DOI:10.1016/S0165-6147(96)01038-3, PMID 9133776.
Gao ZG, Jacobson KA, Emerging adenosine receptor agonists, in Expert Opinion on Emerging Drugs, vol. 12, n. 3, settembre 2007, pp. 479–92, DOI:10.1517/14728214.12.3.479, PMID 17874974.
Haskó G, Pacher P, A2A receptors in inflammation and injury: lessons learned from transgenic animals, in Journal of Leukocyte Biology, vol. 83, n. 3, marzo 2008, pp. 447–55, DOI:10.1189/jlb.0607359, PMC 2268631, PMID 18160539.
Kalda A, Yu L, Oztas E, Chen JF, Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease, in Journal of the Neurological Sciences, vol. 248, n. 1-2, ottobre 2006, pp. 9–15, DOI:10.1016/j.jns.2006.05.003, PMID 16806272.
Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF, Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function, in Physiology & Behavior, vol. 92, n. 1-2, settembre 2007, pp. 210–7, DOI:10.1016/j.physbeh.2007.05.034, PMID 17572452.
Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S, Adenosine A2A receptors and basal ganglia physiology, in Progress in Neurobiology, vol. 83, n. 5, dicembre 2007, pp. 277–92, DOI:10.1016/j.pneurobio.2007.05.001, PMC 2148496, PMID 17646043.
Cunha RA, Ferré S, Vaugeois JM, Chen JF, Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders, in Current Pharmaceutical Design, vol. 14, n. 15, 2008, pp. 1512–24, DOI:10.2174/138161208784480090, PMC 2423946, PMID 18537674.
Peart JN, Headrick JP, Adenosinergic cardioprotection: multiple receptors, multiple pathways, in Pharmacology & Therapeutics, vol. 114, n. 2, maggio 2007, pp. 208–21, DOI:10.1016/j.pharmthera.2007.02.004, PMID 17408751.
Cohen MV, Downey JM, Adenosine: trigger and mediator of cardioprotection, in Basic Research in Cardiology, vol. 103, n. 3, maggio 2008, pp. 203–15, DOI:10.1007/s00395-007-0687-7, PMID 17999026.
Ferré S, An update on the mechanisms of the psychostimulant effects of caffeine, in Journal of Neurochemistry, vol. 105, n. 4, maggio 2008, pp. 1067–79, DOI:10.1111/j.1471-4159.2007.05196.x, PMID 18088379.
Osadchii OE, Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease, in Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy, vol. 21, n. 3, giugno 2007, pp. 171–94, DOI:10.1007/s10557-007-6014-6, PMID 17373584.
Baraldi PG, Tabrizi MA, Gessi S, Borea PA, Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility, in Chemical Reviews, vol. 108, n. 1, gennaio 2008, pp. 238–63, DOI:10.1021/cr0682195, PMID 18181659.
Cristalli G, Lambertucci C, Marucci G, Volpini R, Dal Ben D, A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists, in Current Pharmaceutical Design, vol. 14, n. 15, 2008, pp. 1525–52, DOI:10.2174/138161208784480081, PMID 18537675.
Jacobson KA, Gao ZG, Adenosine receptors as therapeutic targets, in Nature reviews. Drug discovery, vol. 5, n. 3, 2006, pp. 247–64, DOI:10.1038/nrd1983, PMID 16518376.

nih.gov

ncbi.nlm.nih.gov

Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M, Towards a revised nomenclature for P1 and P2 receptors, in Trends Pharmacol. Sci., vol. 18, n. 3, 1997, pp. 79–82, DOI:10.1016/S0165-6147(96)01038-3, PMID 9133776.
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J, International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, in Pharmacol. Rev., vol. 53, n. 4, 2001, pp. 527–52, PMID 11734617.
Gao ZG, Jacobson KA, Emerging adenosine receptor agonists, in Expert Opinion on Emerging Drugs, vol. 12, n. 3, settembre 2007, pp. 479–92, DOI:10.1517/14728214.12.3.479, PMID 17874974.
Haskó G, Pacher P, A2A receptors in inflammation and injury: lessons learned from transgenic animals, in Journal of Leukocyte Biology, vol. 83, n. 3, marzo 2008, pp. 447–55, DOI:10.1189/jlb.0607359, PMC 2268631, PMID 18160539.
Kalda A, Yu L, Oztas E, Chen JF, Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease, in Journal of the Neurological Sciences, vol. 248, n. 1-2, ottobre 2006, pp. 9–15, DOI:10.1016/j.jns.2006.05.003, PMID 16806272.
Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF, Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function, in Physiology & Behavior, vol. 92, n. 1-2, settembre 2007, pp. 210–7, DOI:10.1016/j.physbeh.2007.05.034, PMID 17572452.
Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S, Adenosine A2A receptors and basal ganglia physiology, in Progress in Neurobiology, vol. 83, n. 5, dicembre 2007, pp. 277–92, DOI:10.1016/j.pneurobio.2007.05.001, PMC 2148496, PMID 17646043.
Cunha RA, Ferré S, Vaugeois JM, Chen JF, Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders, in Current Pharmaceutical Design, vol. 14, n. 15, 2008, pp. 1512–24, DOI:10.2174/138161208784480090, PMC 2423946, PMID 18537674.
Peart JN, Headrick JP, Adenosinergic cardioprotection: multiple receptors, multiple pathways, in Pharmacology & Therapeutics, vol. 114, n. 2, maggio 2007, pp. 208–21, DOI:10.1016/j.pharmthera.2007.02.004, PMID 17408751.
Cohen MV, Downey JM, Adenosine: trigger and mediator of cardioprotection, in Basic Research in Cardiology, vol. 103, n. 3, maggio 2008, pp. 203–15, DOI:10.1007/s00395-007-0687-7, PMID 17999026.
Ferré S, An update on the mechanisms of the psychostimulant effects of caffeine, in Journal of Neurochemistry, vol. 105, n. 4, maggio 2008, pp. 1067–79, DOI:10.1111/j.1471-4159.2007.05196.x, PMID 18088379.
Osadchii OE, Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease, in Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy, vol. 21, n. 3, giugno 2007, pp. 171–94, DOI:10.1007/s10557-007-6014-6, PMID 17373584.
Baraldi PG, Tabrizi MA, Gessi S, Borea PA, Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility, in Chemical Reviews, vol. 108, n. 1, gennaio 2008, pp. 238–63, DOI:10.1021/cr0682195, PMID 18181659.
Cristalli G, Lambertucci C, Marucci G, Volpini R, Dal Ben D, A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists, in Current Pharmaceutical Design, vol. 14, n. 15, 2008, pp. 1525–52, DOI:10.2174/138161208784480081, PMID 18537675.
Entrez Gene: ADORA2A adenosine A2A receptor, su ncbi.nlm.nih.gov.
Jacobson KA, Gao ZG, Adenosine receptors as therapeutic targets, in Nature reviews. Drug discovery, vol. 5, n. 3, 2006, pp. 247–64, DOI:10.1038/nrd1983, PMID 16518376.

oadoi.org

Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M, Towards a revised nomenclature for P1 and P2 receptors, in Trends Pharmacol. Sci., vol. 18, n. 3, 1997, pp. 79–82, DOI:10.1016/S0165-6147(96)01038-3, PMID 9133776.
Gao ZG, Jacobson KA, Emerging adenosine receptor agonists, in Expert Opinion on Emerging Drugs, vol. 12, n. 3, settembre 2007, pp. 479–92, DOI:10.1517/14728214.12.3.479, PMID 17874974.
Kalda A, Yu L, Oztas E, Chen JF, Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease, in Journal of the Neurological Sciences, vol. 248, n. 1-2, ottobre 2006, pp. 9–15, DOI:10.1016/j.jns.2006.05.003, PMID 16806272.
Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF, Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function, in Physiology & Behavior, vol. 92, n. 1-2, settembre 2007, pp. 210–7, DOI:10.1016/j.physbeh.2007.05.034, PMID 17572452.
Peart JN, Headrick JP, Adenosinergic cardioprotection: multiple receptors, multiple pathways, in Pharmacology & Therapeutics, vol. 114, n. 2, maggio 2007, pp. 208–21, DOI:10.1016/j.pharmthera.2007.02.004, PMID 17408751.
Cohen MV, Downey JM, Adenosine: trigger and mediator of cardioprotection, in Basic Research in Cardiology, vol. 103, n. 3, maggio 2008, pp. 203–15, DOI:10.1007/s00395-007-0687-7, PMID 17999026.
Ferré S, An update on the mechanisms of the psychostimulant effects of caffeine, in Journal of Neurochemistry, vol. 105, n. 4, maggio 2008, pp. 1067–79, DOI:10.1111/j.1471-4159.2007.05196.x, PMID 18088379.
Osadchii OE, Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease, in Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy, vol. 21, n. 3, giugno 2007, pp. 171–94, DOI:10.1007/s10557-007-6014-6, PMID 17373584.
Baraldi PG, Tabrizi MA, Gessi S, Borea PA, Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility, in Chemical Reviews, vol. 108, n. 1, gennaio 2008, pp. 238–63, DOI:10.1021/cr0682195, PMID 18181659.
Cristalli G, Lambertucci C, Marucci G, Volpini R, Dal Ben D, A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists, in Current Pharmaceutical Design, vol. 14, n. 15, 2008, pp. 1525–52, DOI:10.2174/138161208784480081, PMID 18537675.
Jacobson KA, Gao ZG, Adenosine receptors as therapeutic targets, in Nature reviews. Drug discovery, vol. 5, n. 3, 2006, pp. 247–64, DOI:10.1038/nrd1983, PMID 16518376.

web.archive.org

Unless else specified in boxes, then ref is:senselab Archiviato il 28 febbraio 2009 in Internet Archive.

yale.edu

senselab.med.yale.edu

Unless else specified in boxes, then ref is:senselab Archiviato il 28 febbraio 2009 in Internet Archive.